Dott. Luigi Vicari on 26 novembre 2014

Montreal—Preliminary data indicate reduced postoperative/post-discharge nausea and vomiting (PONV/PDNV) and improved patient satisfaction after a single dose of IV acetaminophen in patients undergoing laparoscopic cholecystectomy, compared with traditional opioid-based anesthetics. Despite this, the overall amount of opioid administered intraoperatively and in the postanesthesia care unit (PACU) was not reduced. Fonte: Anesthesiology News

Continue reading about Post-Op Nausea and Vomiting Reduced With IV Acetaminophen

Dott. Luigi Vicari on 26 novembre 2014

When performing deep sedation in children undergoing magnetic resonance imaging (MRI) studies, anesthesiologists often are on the lookout for a drug that will not inhibit airway patency. A trial by a group of Buffalo researchers has concluded that dexmedetomidine may be one such alternative, as it causes no more airway collapses than propofol in these […]

Continue reading about Dexmedetomidine Promising for Deep Pediatric Sedation

Dott. Luigi Vicari on 26 novembre 2014

Si chiama Touch Tb ed è un manuale multimediale sulla tubercolosi scaricabile gratuitamente da ibook Store. Il progetto è stato realizzato in collaborazione tra il dipartimento di Prevenzione della Asl di Milano e l’Università di Milano, è contiene anche immagini video e animazioni per un percorso interattivo di conoscenza della patologia. E’ dedicato a studenti […]

Continue reading about Nasce un manuale sulla Tubercolosi per operatori e studenti

Patients with atrial fibrillation (AF) receiving antithrombotic treatment are at increased risk for bleeding if they also take a nonsteroidal anti inflammatory drug (NSAID), even for a short period, a new nationwide Danish study has found. The data suggest that a serious bleeding event occurs in up to 1 in 400 to 500 patients with […]

Continue reading about NSAIDs Raise Bleeding, Thromboembolic Risk in Treated Atrial Fibrillation Patient

Dott. Luigi Vicari on 19 novembre 2014

CHICAGO — A new trial shows no benefit of low-dose, once-daily aspirin in the primary prevention of cardiovascular events in patients with multiple risk factors, including hypertension, diabetes, and dyslipidemia. No benefit was seen for the composite endpoint of nonfatal myocardial infarction (MI), nonfatal stroke, or death from cardiovascular causes. There were significant reductions in […]

Continue reading about Low-Dose Aspirin Fails in Primary Prevention